-
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
13 Aug 2025 20:05 GMT
… doris@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
-
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
04 Aug 2025 22:50 GMT
… 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ … forward-looking statements. Contact Cyclacel Pharmaceuticals, Inc.
Email: IR@ … are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc. 1 Yoojin …
-
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
16 Jul 2025 13:00 GMT
… to Cyclacel Pharmaceuticals, Inc., at ir@cyclacel.com. Contacts Cyclacel Pharmaceuticals, … cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?
16 Jul 2025 01:47 GMT
Cyclacel Pharmaceuticals, Inc. CYCC stock is trading …
-
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
07 Jul 2025 10:00 GMT
… to Cyclacel Pharmaceuticals, Inc., at ir@cyclacel.com. Contacts Cyclacel Pharmaceuticals, … cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER
07 Jul 2025 10:00 GMT
… forward-looking statements. Contact Cyclacel Pharmaceuticals, Inc.
Email: IR@ … cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. … ® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc. 1 Chan …
-
Pre-market Movers: KULR, SORA, GLOB, GAMB, AMAT.
15 Aug 2025 18:09 GMT
… over 5% at $10.22.
Cyclacel Pharmaceuticals, Inc. (CYCC) is up over …
-
Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split
03 Jul 2025 13:16 GMT
Cyclacel Pharmaceuticals (CYCC) announced that it expects …
-
Cyclacel Pharmaceuticals Announces Stock Split
02 Jul 2025 13:00 GMT
… 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … future events or otherwise. Contacts Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris … ir@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
20 Jun 2025 20:30 GMT
… 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ … legal counsel to Cyclacel. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical …
About
© 1995-2025